Intelomed Secures $4M in Series A1 Funding

Intelomed, Inc., a Pittsburgh, Pennsylvania-based developer of noninvasive medical devices and technology for monitoring cardiovascular stability, secured $4m in Series A-1 funding.

Backers included new and existing shareholders from Pittsburgh and the New York and California area.

The company intends to use the funds to launch sales efforts and pursue additional clinical validations for newly implemented product features.

Established in 2005 by Frank Amoruso, President and CEO, Intelomed develops CVInsight®, which will be introduced to the Hemodialysis industry and the Long-term Care and Nursing Home industry over the next several months.



Join the discussion